N/A
N=29,134
Evaluating the Impact of Patient-Centered Oncology Care
Neoplasms
Bottom Line
View on ClinicalTrials.gov: NCT02110758 ↗Enrolled (actual)
29,134
Serious AEs
—
Results posted
Mar 2021
Primary outcome: Primary: Change in Patient Experience From Baseline to Follow up — 90.1; 90.0; 92.8; 92.4 units on a scale — p=.025
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Pilot of Patient-Centered Oncology Care (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- National Committee for Quality Assurance
- Primary completion
- Jan 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Patient Experience From Baseline to Follow up |
90.1; 90.0; 92.8; 92.4; 92.1; 91.0 | .025 sig |
| PRIMARY Change in Quality of Care From Baseline to Follow up: Percentage of Patients Receiving Recommended Care |
77.9; 95.7; 74.9; 94.6; 88.3; 79.5 | — |
| PRIMARY Change in Health Care Utilization From Baseline to Follow up |
0.0403; 0.0386; 0.0484; 0.0823; 0.0623; 0.0512 | 0.2 |
Summary
The National Committee for Quality Assurance has worked with the National Coalition for Cancer Survivorship, the American Society of Clinical Oncology, Oncology Management Services, Independence Blue Cross, and RAND, as well as a broader multi-stakeholder advisory group, to define the Patient-Centered Oncology Care model. The purpose of this project was to pilot and evaluate this model. Specific research questions were:
1. Does Patient-Centered Oncology Care improve patient experiences and quality of care? Does it reduce undesirable events like emergency department visits and hospital stays?
2. How does adoption of Patient-Centered Oncology Care vary across a variety of practices and what factors affect adoption?
The demonstration occurred in oncology practices in southeastern Pennsylvania. Practices received implementation support during the 24-month demonstration period. They were evaluated using patient surveys, quality measures, and measures of emergency department and hospital use. Results from these practices were compared in two ways: 1) with their performance before they became oncology medical homes and 2) with other similar practices.
Eligibility Criteria
Inclusion Criteria
Patients:
- Diagnosis of cancer
- Receives care at a pilot or comparison oncology practice located in southeastern Pennsylvania that accepts patients with Independence Blue Cross health insurance
Exclusion Criteria
- Any person that does not meet any of the inclusion criteria
Data sourced from ClinicalTrials.gov (NCT02110758). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.